Key Insights

Highlights

Treatment Research

2 treatments under study, led by Usual Antibiotics Cloxacillin Cefazolin Daptomycin

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04141787Phase 4Unknown

Ceftriaxone as Home IV for Staph Infections

Showing all 1 trials

Research Network

Common Treatments

  • Usual Antibiotics Cloxacillin Cefazolin Daptomycin1
  • Ceftriaxone1

Active Sponsors

  • Vancouver Island Health Authority1

Top Investigators

Related Conditions

  • Abscess1
  • Cns Infection1
  • Diabetic Foot Infection1
  • Osteomyelitis1
  • Staphylococcal Infections1

Activity Timeline